dc.contributor.author |
Chutinimitkul S. |
|
dc.contributor.author |
Bhattarakosol P. |
|
dc.contributor.author |
Srisuratanon S. |
|
dc.contributor.author |
Eiamudomkan A. |
|
dc.contributor.author |
Kongsomboon K. |
|
dc.contributor.author |
Damrongwatanapokin S. |
|
dc.contributor.author |
Chaisingh A. |
|
dc.contributor.author |
Suwannakarn K. |
|
dc.contributor.author |
Chieochansin T. |
|
dc.contributor.author |
Theamboonlers A. |
|
dc.contributor.author |
Poovorawan Y. |
|
dc.date.accessioned |
2021-04-05T04:32:25Z |
|
dc.date.available |
2021-04-05T04:32:25Z |
|
dc.date.issued |
2006 |
|
dc.identifier.issn |
10806040 |
|
dc.identifier.other |
2-s2.0-33744906091 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/15058 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744906091&doi=10.3201%2feid1206.060227&partnerID=40&md5=1336a3cf146f79b5b92ded2a32536d99 |
|
dc.description.abstract |
[No abstract available] |
|
dc.subject |
antiinfective agent |
|
dc.subject |
midecamycin |
|
dc.subject |
oseltamivir |
|
dc.subject |
oxygen |
|
dc.subject |
penicillin G |
|
dc.subject |
sialidase |
|
dc.subject |
virus RNA |
|
dc.subject |
amino acid sequence |
|
dc.subject |
blood sampling |
|
dc.subject |
cerebrospinal fluid |
|
dc.subject |
clinical feature |
|
dc.subject |
epidemic |
|
dc.subject |
human |
|
dc.subject |
Influenza virus A |
|
dc.subject |
laboratory test |
|
dc.subject |
letter |
|
dc.subject |
nonhuman |
|
dc.subject |
nucleotide sequence |
|
dc.subject |
oxygen therapy |
|
dc.subject |
phylogeny |
|
dc.subject |
plasma |
|
dc.subject |
reverse transcription polymerase chain reaction |
|
dc.subject |
serodiagnosis |
|
dc.subject |
virus transmission |
|
dc.title |
H5N1 influenza A virus and infected human plasma [7] |
|
dc.type |
Letter |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Emerging Infectious Diseases. Vol 12, No.6 (2006), p.1041-1043 |
|
dc.identifier.doi |
10.3201/eid1206.060227 |
|